Metformin and Malignant Tumors: Not Over the Hill [Response to Letter]
Weiling Leng,1,* Juan Jiang,2,* Bing Chen,1 Qinan Wu3 1Endocrinology Department, The First Affiliated Hospital of the Third Military Medical University (Army Medical University), Chongqing, People’s Republic of China; 2Endocrinology and Nephrology Department, Chongqing University Cancer Ho...
Enregistré dans:
Auteurs principaux: | Leng W, Jiang J, Chen B, Wu Q |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4d4b7314b6b44630ae57461f54d7ea3d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Metformin and Malignant Tumors: Not Over the Hill
par: Leng W, et autres
Publié: (2021) -
Metformin and Malignant Tumors: Not Over the Hill: A Short Comment [Letter]
par: Rastmanesh R
Publié: (2021) -
Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
par: Leng W, et autres
Publié: (2021) -
An easily ignored factor for CAN-fine particulate exposure [Response to Letter]
par: Vasheghani M
Publié: (2019) -
Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
par: Bruckbauer A, et autres
Publié: (2013)